Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals

J Clin Virol. 2022 Jun:150-151:105158. doi: 10.1016/j.jcv.2022.105158. Epub 2022 Apr 12.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral
  • COVID-19*
  • Enzyme-Linked Immunospot Assay
  • Humans
  • SARS-CoV-2*
  • T-Lymphocytes

Substances

  • Antibodies, Viral